TONX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

TON Strategy Co · Technology · Software - Application

Open interactive chart View report data
Latest close 2.98 USD
-8.0% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 5.5% above the Trend Line and sits at 10.1% of its 52-week range. The latest completed week returned -8.0%, after a 3.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 31/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 44 out of 100
Latest Close 2.98 USD 31 Jul 2026
1W Return -8.0% latest completed week
4W Return 3.5% short-term follow-through
12W Return -18.1% quarterly tape
Trend Breadth 20.8% 10 of 48 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 10-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Next-week expectancy is positive at 55.89% based on similar historical setup states.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -8.0% Latest completed week; four-week move 3.5%. Indicator stack 46/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.89% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 31/100 conviction; expected move 24.5%. News sentiment 52/100 24 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 5.5% above the Trend Line and sits at 10.1% of its 52-week range. The latest completed week returned -8.0%, after a 3.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3312-week average 0.28

12-week confirmation

Trend active10/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.33Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

8 accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.5% over four weeks, -18.1% over 12 weeks, and - over one year. The current trend has remained active for 10 consecutive weeks.

Performance by holding period

1W-8.0%
4W3.5%
12W-18.1%
26W14.2%
52W-
Active trend streak10 weeks
Active weeks in one year10
Trend breadth20.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.51Latest activity-pressure read.
Pressure change-61.8%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 70% Model confidence 67%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength35/100Blend of value, momentum, and quality. Underlying universe rank 66; rank 1 is best.
Value43/100Relative valuation strength. Underlying universe rank 58; rank 1 is best.
Quality41/100Profitability and accounting quality. Underlying universe rank 60; rank 1 is best.
Momentum43/100Medium-term price momentum. Underlying universe rank 58; rank 1 is best.
Growth43/100Revenue and earnings growth. Underlying universe rank 58; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
10.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-15.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
71.0%
Gross profit retained from each unit of revenue.
Operating margin
-897.2%
Operating profit retained from revenue.
Free-cash-flow margin
-145.6%
Free cash flow generated from revenue.
Return on invested capital
-39.9%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
662.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

TONX shows mixed options pressure with a 31/100 conviction score, put-call volume ratio of n/a, expected move of 24.5%, and Sharemaestro trend signal active.

Conviction31/100
Expected move24.5%
Put/call volume
Pressure-12
Speculation0
Volatility96
Trend agreement62
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 24 relevant articles.

4 positive · 20 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move24.5%Nearest-chain priced movement where available.
52-week drawdown-78.6%Distance below the 52-week high.
13-week volatility22.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+71.7%Week of 8 May.
Worst week-24.9%Week of 6 Feb.
Latest week-8.0%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains5
Flat weeks0
Modest losses3
Sharp losses9
Recent vol22.1%13-week weekly-return volatility.
Base vol18.2%52-week weekly-return volatility.
Up/down split22/25Count of positive and negative weeks in the 52-week window.
Average skew12.6% / -13.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis65/100

Latest 12-week confirmation: trend 10/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.33; No reversal markers Next-Week ExpectancyPositive 55.89%

Next-week expectancy is positive with a 55.89% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors39/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 59 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options48/100

TONX shows mixed options pressure with a 31/100 conviction score, put-call volume ratio of n/a, expected move of 24.5%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 24.5% Sentiment52/100

Weighted news tone is neutral across 24 relevant articles.

TON Strategy Ord Shs (TONX) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.98 USD-8.0%2.82 USD3.47 USD0.51-1.5MOn
24 Jul 20263.24 USD-0.6%2.81 USD3.48 USD0.75-1.3MOn
17 Jul 20263.26 USD1.6%2.77 USD3.48 USD0.96-1.3MOn
10 Jul 20263.21 USD11.5%2.74 USD3.49 USD1.21-2.8MOn
3 Jul 20262.88 USD12.5%2.73 USD3.50 USD1.35-3.8MOn
26 Jun 20262.56 USD-23.6%2.73 USD3.51 USD1.54-2.0MOn
19 Jun 20263.35 USD6.3%2.76 USD3.53 USD1.76-1.2MOn
12 Jun 20263.15 USD1.3%2.74 USD3.54 USD1.93-1.1MOn
5 Jun 20263.11 USD-21.9%2.75 USD3.55 USD2.10-1.6MOn
29 May 20263.98 USD1.0%2.76 USD3.56 USD2.15-1.4MOn
22 May 20263.94 USD7.4%2.77 USD3.55 USD1.86-2.4MOff
15 May 20263.67 USD0.8%2.77 USD3.54 USD1.46-3.4MOff
8 May 20263.64 USD71.7%2.77 USD3.53 USD1.09-4.5MOff
1 May 20262.12 USD-10.9%2.83 USD3.53 USD0.71-1.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.